Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies

Toxicologic Pathology

Volumn 26, Issue 4, 1998, Pages 520-531

  Mitsumori, Kunitoshi ^a   Koizumi, Haruko ^b   Nomura, Tatsuji ^b   Yamamoto, Satoshi ^b,c  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

6 mo carcinogenicity testing; Carcinogens; Chemical carcinogenesis; Human prototype c Ha ras transgenic mice; Induced tumors; Morphology; rasH2 mice; Spontaneous tumors

Indexed keywords

ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CARCINOGEN TESTING; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; LUNG ADENOMA; MALE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN PAPILLOMA; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0031854359     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339802600408     Document Type: Article

References (50)

1. Ando K, Saitoh A, Hino O, Takahashi R, Kimura M, and Katsuki M (1992). Chemically induced forestomach papillomas in transgenic mice carrying mutant human c-Ha-ras transgenes. Cancer Res. 52: 978-982.
2. Dahl GA, Miller EC, and Miller JA (1980). Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate. Cancer Res. 40: 1194-1203.
3. Davies TS and Monro A (1995). Marketed pharmaceuticals reported to be tumorigenic in rodents. J. Am. Coll. Toxicol. 14: 90-107.
4. Diwan BA, Rice JM, Ohshima M, and Ward JM (1986). Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/ 6NCr, C3H/HeNCrMTV-and DBA/2NCr. Carcinogenesis 7: 215-220.
5. Doi ST, Kimura M, and Katsuki M (1994). Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice. Jpn. J. Cancer Res. 85: 801-807.
6. Dragani TA, Manenti G, and Della Porta G (1991). Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res. 51: 6299-6303.
7. Frith CH and Ward JM (1988). Color Atlas of Neoplastic and Non-neoplastic Lesions in Aging Mice. Elsevier, Amsterdam.
8. Hawkins BL, Heniford BW, Ackermann DM, Leonberger M, Martinez SA, and Hendler SJ (1994). 4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma. Head & Neck 16: 424-432.
9. Hoffmann D, Rivenson A, Chung FL, and Hecht SS (1991). Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. Crit. Rev. Toxicol. 21:305-311.
10. International Agency for Research on Cancer (1978). N-Nitrosodiethylamine. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 17, Some N-Nitroso Compounds. International Agency for Research on Cancer, Lyon, France, pp. 83-124.
11. International Agency for Research on Cancer (1978). N-Nitroso-N-methylurea. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 17, Some N-Nitroso Compounds. International Agency for Research on Cancer, Lyon, France, pp. 227-255.
12. International Agency for Research on Cancer (1981). Cyclophosphamide. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 26, Some Antineoplastic and Immunosuppressive Agents. International Agency for Research on Cancer, Lyon, France, pp. 165-202.
13. International Agency for Research on Cancer (1987). Melphalan. In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vols. 1-42, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. International Agency for Research on Cancer, Lyon, France, pp. 239-240.
14. International Agency for Research on Cancer (1987). N-Methyl-N-nitro-N-nitrosoguanidine (MNNG). In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vols. 1-42, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monograph. International Agency for Research on Cancer, Lyon, France, pp. 248-250.
15. International Agency for Research on Cancer (1987). Phenacetin. In: IAAC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vols. 1-42, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. International Agency for Research on Cancer, Lyon, France, pp. 310-312.
16. International Agency for Research on Cancer (1990). Ciclosporin. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 50, Pharmaceutical Drugs. International Agency for Research on Cancer, Lyon, France, pp. 77-114.
17. 1 mouse lung lesions induced by urethane. Jpn. J. Cancer Res. 86: 802-810.
18. Kumagai H, Kawaura A, Furuya K, Izumi K, and Otsuka H (1982). Perianal lesions of BALB/c mice induced by 1,2-dimethylhydrazine dihydrochloride and methylazoxymethanol-acetate: Their classification and histogenesis. Gann 73: 358-364.
19. Malkinson AM (1982). The genetic basis of susceptibility to lung tumors in mice. Toxicology 54: 241-271.
20. 1 (C57BL/6JÅ∼BALB/cJ) mice. Carcinogenesis 16: 1065-1069.
21. Mitsumori K, Wakana S, Yamamoto S, Kodama Y, Yasuhara K, Nomura T, Hayashi Y, and Maronpot RR (1997). Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses on the induced tumors. Mol. Carcinog. 20: 298-307.
22. Monro AM (1996). Testing for carcinogenic potential. Proc. Int. Conf. Harmonization 3: 261-268.
23. 1 Mice (Gavage Studies). Technical Report Series No. 403. National Toxicology Program, Research Triangle Park, North Carolina.
24. National Toxicology Program (1993). TR-19 Bioassay of procarbazine for possible carcinogenicity (CAS: 336-70-1). Environ. Health Perspect. 101(suppl. 1): 14.
25. National Toxicology Program (1993). TR-47 Bioassay of 4,4′-thiodianiline for possible carcinogenicity (CAS: 139-65-1). Environ. Health Perspect. 101(suppl. 1): 30.
26. National Toxicology Program (1993). TR-58 Bioassay of Thio-TEPA for possible carcinogenicity (CAS: 52-24-4). Environ. Health Perspect. 101(suppl. 1): 37-38.
27. National Toxicology Program (1993). TR-80 Bioassay of 1,4-dioxane for possible carcinogenicity (CAS: 123-91-1). Environ. Health Perspect. 101(suppl. 1): 50.
28. National Toxicology Program (1993). TR-116 Bioassay of p-anisidine hydrochloride for possible carcinogenicity (CAS: 20265-97-8). Environ. Health Perspect. 101(suppl. 1): 69.
29. National Toxicology Program (1993). TR-142 Bioassay of p-cresidine for possible carcinogenicity (CAS: 120-71-8). Environ. Health Perspect. 101(suppl. 1): 81-82.
30. National Toxicology Program (1993). TR-180 Bioassay of 4-nitro-o-phenylenediamine for possible carcinogenicity (CAS: 99-56-9). Environ. Health Perspect. 101(suppl. 1): 101-102.
31. 1 mice. Environ. Health Perspect. 101(suppl. 1): 143.
32. 1 mice (feed studies). Environ. Health Perspect. 101(suppl. 1): 152.
33. 1 mice (gavage studies). Environ. Health Perspect. 101(suppl. 1): 160-161.
34. 1 mice (feed studies). Environ. Health Perspect. 101(suppl. 1): 186-187.
35. 1 mice (gavage studies). Environ. Health Perspect. 101(suppl. 1): 193-194.
36. 1 mice (dermal studies). Environ. Health Perspect. 101(suppl. 1): 238-239.
37. 1 mice (gavage studies). Environ. Health Perspect. 101(suppl. 1): 260-261.
38. 1 mice (feed studies). Environ. Health Perspect. 101(suppl. 1): 264-266.
39. Ogawa K, Imaida K, Masui T, Kawabe M, Hasegawa R, Kato K, Ito N, and Shirai T (1996). Chemically induced lung and forestomach neoplasias in transgenic mice carrying mutant forms of the human c-Ha-ras transgene. Carcinogenesis 17: 341-345.
40. Rao MS, Subbarao V, and Scarpelli DG (1987). Atypical acinar cell lesions of the pancreas in mice induced by 4-hydroxyaminoquinoline-1-oxide. Int. J. Pancreatol. 2: 1-10.
41. Ryan J, Barker PE, Nesbitt MN, and Ruddle FH (1987). KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J. Natl. Cancer Inst. 79: 1351-1357.
42. Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, and Katsuki M (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5: 1195-1200.
43. Stanley LA, Devereux TR, Foley J, Lord PG, Maronpot RR, Orton TC, and Anderson MW (1992). Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis 13: 2427-2433.
44. Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103: 942-950.
45. Thurnherr N, Deschner EE, Stonehill EH, and Lipkin M (1973). Induction of adenocarcinomas of the colon in mice by weekly injection of 1,2-dimethylhydrazine. Cancer Res. 33: 940-945.
46. Turusov V and Mohr U (1994). Pathology of Tumours in Laboratory Animals, Vol. 2, Tumours of the Mouse. International Agency for Research on Cancer, Lyon, France.
47. Urano K, Koizumi H, Nagase S, Watanabe Y, Jiang H, Nomura T, and Yamamoto S (1998). Rapid carcinogenic response of transgenic mice harboring the human prototype c-Ha-ras gene to various carcinogens. Prog. Clin. Biol. Res. (in press).
48. Yamamoto S, Hayashi Y, Mitsumori K, and Nomura T (1997). Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab. Anim. Sci. 47: 121-126.
49. Yamamoto S, Mitsumori K, Kodama Y, Matsunuma N, Manabe S, Okamiya H, Suzuki H, Fukuda T, Sakamaki Y, Sunaga M, Nomura G, Hioki K, Wakana S, Nomura T, and Hayashi Y (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring human prototype c-Ha-ras gene than in control nontransgenic mice. Carcinogenesis 17: 2455-2461.
50. Yamamoto S, Urano K, Koizumi H, Wakana S, Hioki K, Mitsumori K, Kurokawa K, Hayashi Y, and Nomura T (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. (in press).